Article

Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions

Department of Neuroscience, Uppsala University, Box 593, Husargatan 3, Uppsala, Sweden.
Molecular Neurobiology (Impact Factor: 5.29). 12/2011; 46(1):4-10. DOI: 10.1007/s12035-011-8229-6
Source: PubMed

ABSTRACT Insulin receptors in the brain are found in high densities in the hippocampus, a region that is fundamentally involved in the acquisition, consolidation, and recollection of new information. Using the intranasal method, which effectively bypasses the blood-brain barrier to deliver and target insulin directly from the nose to the brain, a series of experiments involving healthy humans has shown that increased central nervous system (CNS) insulin action enhances learning and memory processes associated with the hippocampus. Since Alzheimer's disease (AD) is linked to CNS insulin resistance, decreased expression of insulin and insulin receptor genes and attenuated permeation of blood-borne insulin across the blood-brain barrier, impaired brain insulin signaling could partially account for the cognitive deficits associated with this disease. Considering that insulin mitigates hippocampal synapse vulnerability to amyloid beta and inhibits the phosphorylation of tau, pharmacological strategies bolstering brain insulin signaling, such as intranasal insulin, could have significant therapeutic potential to deter AD pathogenesis.

Full-text

Available from: Christian Benedict, Jun 03, 2015
1 Follower
 · 
179 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cerebral microvascular impairments occurring in Alzheimer's disease may reduce amyloid-beta (Aβ) peptide clearance and impact upon circulatory ultrastructure and function. We hypothesised that microvascular pathologies occur in organs responsible for systemic Aβ peptide clearance in a model of Alzheimer's disease and that Liraglutide (Victoza(®) ) improves vessel architecture. Seven month old APPswe /PS1dE9 (APP/PS1) and age-matched wild-type mice received once-daily intraperitoneal injections of either Liraglutide or saline (n=4 per group) for eight weeks. Casts of cerebral, splenic, hepatic and renal microanatomy were analysed using scanning electron microscopy. Casts from wild-type mice showed regularly spaced microvasculature with smooth lumenal profiles, whereas APP/PS1 mice revealed evidence of microangiopathies including cerebral microanuerysms, intracerebral microvascular leakage, extravasation from renal glomerular microvessels and significant reductions in both splenic sinus density (p=0.0286) and intussusceptive microvascular pillars (p=0.0412). Quantification of hepatic vascular ultrastructure in APP/PS1 mice revealed that vessel parameters (width, length, branching points, intussusceptive pillars and microaneurysms) were not significantly different from wild-type mice. Systemic administration of Liraglutide reduced the incidence of cerebral microanuerysms and leakage, restored renal microvascular architecture and significantly increased both splenic venous sinus number (p=0.0286) and intussusceptive pillar formation (p=0.0129). Liraglutide restores cerebral, splenic and renal architecture in APP/PS1 mice. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Microcirculation (New York, N.Y.: 1994) 12/2014; DOI:10.1111/micc.12186 · 2.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: CONTEXT: Insulin receptors are ubiquitously found in the human brain, comprising the olfactory bulb, essential for odor processing, and the hippocampus, important for spatial memory processing. OBJECTIVE: The present study aimed at examining if intranasal insulin, which is known to transiently increase brain insulin levels in humans, would improve odor-cued reactivation of spatial memory in young men. DESIGN: We applied a double-blind, placebo-controlled, counterbalanced within-subject design. SETTING: The study was conducted at the research unit of a university hospital. Interventions/Participants/Main Outcome Measures: Following intranasal administration of either insulin (40 I.U.) or placebo, male subjects (n = 18) were exposed to eight odors. During each odor exposure, a green-colored field was presented on a 17-in. computer screen. During immediate recall (comprising 3 runs), the participants were re-exposed to each odor cue, and were asked to select the corresponding field (with visual feedback after each response). The delayed recall was scheduled approximately 10 min later (without feedback). To test if insulin's putative effect on odor-place memory would be domain-specific, participants also performed a separate place and odor recognition task. RESULTS: Intranasal insulin improved the delayed but not immediate odor-cued recall of spatial memory. This effect was independent of odor type and in the absence of systemic side effects (eg, fasting plasma glucose levels remained unaltered). Place and odor recognition were unaffected by the insulin treatment. CONCLUSIONS: These findings suggest that acute intranasal insulin improves odor-cued reactivation of spatial memory in young men.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The potential effects of Bisphenol A (BPA) on peripheral insulin resistance have recently gained more attention, however, its functions on brain insulin resistance are still unknown. The aim of the present study was to investigate the effects of BPA on insulin signaling and glucose transport in mouse brain. The male mice were administrated of 100 μg/kg/day BPA or vehicle for 15 days then challenged with glucose and insulin tolerance tests. The insulin levels were detected with radioimmunoassay (RIA), and the insulin signaling pathways were investigated by Western blot. Our results revealed that BPA significantly increased peripheral plasma insulin levels, and decreased the insulin signals including phosphorylated insulin receptor (p-IR), phosphorylated insulin receptor substrate 1 (p-IRS1), phosphorylated protein kinase B (p-AKT), phosphorylated glycogen synthase kinase 3β (p-GSK3β) and phosphorylated extracellular regulated protein kinases (p-ERK1/2) in the brain, though insulin expression in both hippocampus and profrontal cortex was increased. In parallel, BPA exposure might contribute to glucose transport disturbance in the brain since the expression of glucose transporters were markedly decreased. In conclusion, BPA exposure perturbs the insulin signaling and glucose transport in the brain, therefore, it might be a risk factor for brain insulin resistance.
    General and Comparative Endocrinology 01/2015; 212. DOI:10.1016/j.ygcen.2015.01.017 · 2.67 Impact Factor